We are increasingly able to turn to non-surgical therapies for structural and valvular heart disease. Host Dr. Lee Freedman discusses investigational, catheter-based treatment with Dr. Howard Herrmann, professor of medicine, and director of interventional cardiology and the Cardiac Catheterization Laboratories within the University of Pennsylvania Health System. What new devices are making these advances possible? What are the procedural risks?
Investigational Approaches to Structural and Valvular Heart Disease

Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
We are increasingly able to turn to non-surgical therapies for structural and valvular heart disease. Host Dr. Lee Freedman discusses investigational, catheter-based treatment with Dr. Howard Herrmann, professor of medicine, and director of interventional cardiology and the Cardiac Catheterization Laboratories within the University of Pennsylvania Health System. What new devices are making these advances possible? What are the procedural risks?
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Digital Therapeutics Clinical Trials: From Design to Data Interpretation
Identifying the Great Imitator – Demystifying the Systemic Features of IgG4-Related Disease
IgG4-RD Case Conversations: The Peculiarities of Kidney Involvement
IgG4-RD Case Conversations: Retroperitoneal Fibrosis with Refractory Ureteral Involvement
Optimizing PPD Diagnosis and Treatment: The Role of Neuroactive Steroids and Multidisciplinary Care
New Horizons: Unraveling Novel Therapies for Enhanced Cardiovascular Outcomes in Patients With Heart Failure
Level Up Your Skills: Tailoring Management of HF
Advancing TROP-2-Targeted ADCs in HR+ Breast Cancer: Navigating Today and Shaping Tomorrow
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?